194 related articles for article (PubMed ID: 18216107)
1. Analysis of the evolutionary forces in an immunodominant CD8 epitope in hepatitis C virus at a population level.
Neumann-Haefelin C; Frick DN; Wang JJ; Pybus OG; Salloum S; Narula GS; Eckart A; Biezynski A; Eiermann T; Klenerman P; Viazov S; Roggendorf M; Thimme R; Reiser M; Timm J
J Virol; 2008 Apr; 82(7):3438-51. PubMed ID: 18216107
[TBL] [Abstract][Full Text] [Related]
2. Genetic variability of hepatitis C virus non-structural protein 3 and virus-specific CD8+ response in patients with chronic hepatitis C.
López-Labrador FX; He XS; Berenguer M; Cheung RC; González-Candelas F; Wright TL; Greenberg HB
J Med Virol; 2004 Apr; 72(4):575-85. PubMed ID: 14981760
[TBL] [Abstract][Full Text] [Related]
3. Impact of sequence variation in a dominant HLA-A*02-restricted epitope in hepatitis C virus on priming and cross-reactivity of CD8+ T cells.
Ziegler S; Skibbe K; Walker A; Ke X; Heinemann FM; Heinold A; Mok JY; van Esch WJ; Yang D; Wölfl M; Timm J
J Virol; 2014 Oct; 88(19):11080-90. PubMed ID: 25008925
[TBL] [Abstract][Full Text] [Related]
4. Distinct Escape Pathway by Hepatitis C Virus Genotype 1a from a Dominant CD8+ T Cell Response by Selection of Altered Epitope Processing.
Walker A; Skibbe K; Steinmann E; Pfaender S; Kuntzen T; Megger DA; Groten S; Sitek B; Lauer GM; Kim AY; Pietschmann T; Allen TM; Timm J
J Virol; 2016 Jan; 90(1):33-42. PubMed ID: 26446603
[TBL] [Abstract][Full Text] [Related]
5. CD8 epitope escape and reversion in acute HCV infection.
Timm J; Lauer GM; Kavanagh DG; Sheridan I; Kim AY; Lucas M; Pillay T; Ouchi K; Reyor LL; Schulze zur Wiesch J; Gandhi RT; Chung RT; Bhardwaj N; Klenerman P; Walker BD; Allen TM
J Exp Med; 2004 Dec; 200(12):1593-604. PubMed ID: 15611288
[TBL] [Abstract][Full Text] [Related]
6. Escape from a dominant HLA-B*15-restricted CD8+ T cell response against hepatitis C virus requires compensatory mutations outside the epitope.
Ruhl M; Chhatwal P; Strathmann H; Kuntzen T; Bankwitz D; Skibbe K; Walker A; Heinemann FM; Horn PA; Allen TM; Hoffmann D; Pietschmann T; Timm J
J Virol; 2012 Jan; 86(2):991-1000. PubMed ID: 22072759
[TBL] [Abstract][Full Text] [Related]
7. Differential escape of HCV from CD8
Xia Y; Pan W; Ke X; Skibbe K; Walker A; Hoffmann D; Lu Y; Yang X; Feng X; Tong Q; Timm J; Yang D
J Viral Hepat; 2019 Jan; 26(1):73-82. PubMed ID: 30260541
[TBL] [Abstract][Full Text] [Related]
8. Escape from HLA-B*08-restricted CD8 T cells by hepatitis C virus is associated with fitness costs.
Salloum S; Oniangue-Ndza C; Neumann-Haefelin C; Hudson L; Giugliano S; aus dem Siepen M; Nattermann J; Spengler U; Lauer GM; Wiese M; Klenerman P; Bright H; Scherbaum N; Thimme R; Roggendorf M; Viazov S; Timm J
J Virol; 2008 Dec; 82(23):11803-12. PubMed ID: 18815309
[TBL] [Abstract][Full Text] [Related]
9. CD8+ T-cell response promotes evolution of hepatitis C virus nonstructural proteins.
Ruhl M; Knuschke T; Schewior K; Glavinic L; Neumann-Haefelin C; Chang DI; Klein M; Heinemann FM; Tenckhoff H; Wiese M; Horn PA; Viazov S; Spengler U; Roggendorf M; Scherbaum N; Nattermann J; Hoffmann D; Timm J;
Gastroenterology; 2011 Jun; 140(7):2064-73. PubMed ID: 21376049
[TBL] [Abstract][Full Text] [Related]
10. Relation between viral fitness and immune escape within the hepatitis C virus protease.
Söderholm J; Ahlén G; Kaul A; Frelin L; Alheim M; Barnfield C; Liljeström P; Weiland O; Milich DR; Bartenschlager R; Sällberg M
Gut; 2006 Feb; 55(2):266-74. PubMed ID: 16105887
[TBL] [Abstract][Full Text] [Related]
11. Targeting naturally occurring epitope variants of hepatitis C virus with high-affinity T-cell receptors.
Zhang H; Zhang J; Chen L; Weng Z; Tian Y; Zhao H; Li Y; Chen L; Liang Z; Zheng H; Zhao W; Zhong S; Li Y
J Gen Virol; 2017 Mar; 98(3):374-384. PubMed ID: 27902325
[TBL] [Abstract][Full Text] [Related]
12. Positive selection of cytotoxic T lymphocyte escape variants during acute hepatitis C virus infection.
Guglietta S; Garbuglia AR; Pacciani V; Scottà C; Perrone MP; Laurenti L; Spada E; Mele A; Capobianchi MR; Taliani G; Folgori A; Vitelli A; Ruggeri L; Nicosia A; Piccolella E; Del Porto P
Eur J Immunol; 2005 Sep; 35(9):2627-37. PubMed ID: 16114108
[TBL] [Abstract][Full Text] [Related]
13. Conservation of hepatitis C virus nonstructural protein 3 amino acid sequence in viral isolates during liver transplantation.
Mello IM; Thumann C; Schvoerer E; Soulier E; Pinho JR; Silvestre DA; Queiroz AT; Wolf P; Baumert TF; Keller FS; Pereira CA
J Viral Hepat; 2009 Oct; 16(10):732-7. PubMed ID: 19486468
[TBL] [Abstract][Full Text] [Related]
14. HLA-B*27 subtype specificity determines targeting and viral evolution of a hepatitis C virus-specific CD8+ T cell epitope.
Nitschke K; Barriga A; Schmidt J; Timm J; Viazov S; Kuntzen T; Kim AY; Lauer GM; Allen TM; Gaudieri S; Rauch A; Lange CM; Sarrazin C; Eiermann T; Sidney J; Sette A; Thimme R; López D; Neumann-Haefelin C
J Hepatol; 2014 Jan; 60(1):22-9. PubMed ID: 23978718
[TBL] [Abstract][Full Text] [Related]
15. HLA class I allele associations with HCV genetic variants in patients with chronic HCV genotypes 1a or 1b infection.
Lange CM; Roomp K; Dragan A; Nattermann J; Michalk M; Spengler U; Weich V; Lengauer T; Zeuzem S; Berg T; Sarrazin C
J Hepatol; 2010 Dec; 53(6):1022-8. PubMed ID: 20800922
[TBL] [Abstract][Full Text] [Related]
16. Evidence of viral adaptation to HLA class I-restricted immune pressure in chronic hepatitis C virus infection.
Gaudieri S; Rauch A; Park LP; Freitas E; Herrmann S; Jeffrey G; Cheng W; Pfafferott K; Naidoo K; Chapman R; Battegay M; Weber R; Telenti A; Furrer H; James I; Lucas M; Mallal SA
J Virol; 2006 Nov; 80(22):11094-104. PubMed ID: 17071929
[TBL] [Abstract][Full Text] [Related]
17. Human leukocyte antigen-associated sequence polymorphisms in hepatitis C virus reveal reproducible immune responses and constraints on viral evolution.
Timm J; Li B; Daniels MG; Bhattacharya T; Reyor LL; Allgaier R; Kuntzen T; Fischer W; Nolan BE; Duncan J; Schulze zur Wiesch J; Kim AY; Frahm N; Brander C; Chung RT; Lauer GM; Korber BT; Allen TM
Hepatology; 2007 Aug; 46(2):339-49. PubMed ID: 17559151
[TBL] [Abstract][Full Text] [Related]
18. [A HLA-A2-restricted-CTL epitope variation at the N-terminal of HCV helicase and the immune response of CTLs].
Guo HZ; Wang WL; Wang T
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2004 May; 20(3):325-7. PubMed ID: 15193229
[TBL] [Abstract][Full Text] [Related]
19. Cross-genotype-reactivity of the immunodominant HCV CD8 T-cell epitope NS3-1073.
Fytili P; Dalekos GN; Schlaphoff V; Suneetha PV; Sarrazin C; Zauner W; Zachou K; Berg T; Manns MP; Klade CS; Cornberg M; Wedemeyer H
Vaccine; 2008 Jul; 26(31):3818-26. PubMed ID: 18582999
[TBL] [Abstract][Full Text] [Related]
20. Evidence of CD4
Lucas M; Deshpande P; James I; Rauch A; Pfafferott K; Gaylard E; Merani S; Plauzolles A; Lucas A; McDonnell W; Kalams S; Pilkinton M; Chastain C; Barnett L; Prosser A; Mallal S; Fitzmaurice K; Drummer H; Ansari MA; Pedergnana V; Barnes E; John M; Kelleher D; Klenerman P; Gaudieri S
Sci Rep; 2018 May; 8(1):7224. PubMed ID: 29740042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
